home · filing · 0001104659-24-041558
8-K filed April 1, 2024, 7:59 PM ET
ticker ELAN
CIK 0001739104
leadership
confidence high
sentiment neutral
materiality 0.65
Elanco appoints two directors, reaches cooperation agreement with Ancora
Elanco Animal Health Inc
Appointed Kathy Turner and Craig Wallace to the Board effective March 29, 2024; Board size increased from 12 to 14.
Turner and Wallace join the renamed Finance, Strategy and Oversight Committee.
Cooperation Agreement with Ancora includes standstill, voting commitments, and non-disparagement provisions.
Turner held senior roles at IDEXX and Abbott; Wallace has 30+ years at Fort Dodge, Trupanion, and Ceva.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-03-29
Filed April 1, 2024, 7:59 PM ET
On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.
Effective 2024-03-29
Filed April 1, 2024, 7:59 PM ET
On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Craig Wallace was appointed as Director at Elanco Animal Health Inc.
Action appointed
Role Director
Exact text from the filing
On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kathy Turner was appointed as Director at Elanco Animal Health Inc.
Action appointed
Role Director
Exact text from the filing
On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-24-041558
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.